Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
28 hedge funds and large institutions have $8.08M invested in Lumos Pharma, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 9 closing their positions.
68% more capital invested
Capital invested by funds: $4.82M → $8.08M (+$3.26M)
20% less funds holding
Funds holding: 35 → 28 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.98M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$27.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$18.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$969K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$328K |
| 3 |
LPC
Lion Point Capital
New York
|
-$142K |
| 4 |
Goldman Sachs
New York
|
-$123K |
| 5 |
Millennium Management
New York
|
-$85.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $50 | – | – | – |
|
|
LOIP
27
Live Oak Investment Partners
Austin,
Texas
| $43 | – | – | – |
|
28
Jones Financial Companies
Des Peres,
Missouri
| $16 | – | – | – |
|
|
AI
29
Acuitas Investments
Seattle,
Washington
| – | -$328K | -141,435 | Closed |
|
|
30
Millennium Management
New York
| – | -$85.9K | -37,018 | Closed |
|
|
MAM
31
Marquette Asset Management
Minneapolis,
Minnesota
| – | -$59.8K | -25,760 | Closed |
|
32
Envestnet Asset Management
Chicago,
Illinois
| – | -$45.2K | -19,475 | Closed |
|
33
Citadel Advisors
Miami,
Florida
| – | -$43.5K | -18,745 | Closed |
|
|
AI
34
Atria Investments
Charlotte,
North Carolina
| – | -$25.1K | -10,803 | Closed |
|
|
RWMG
35
Redwood Wealth Management Group
Medford,
New Jersey
| – | -$1.16K | -500 | Closed |
|
|
IAIM
36
International Assets Investment Management
Orlando,
Florida
| – | -$88 | -38 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$78 | -28 | -36% |
|
38
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$7 | -3 | Closed |
|
LUMO Hedge Fund Activity: Q3 2024 in Review
28 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q3 2024, worth a combined $8.08M — up 68% from $4.82M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LUMO and 2 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 2 added.
The largest buyer was Private Advisor Group, adding an estimated $1.98M. The largest seller was Wells Fargo, cutting an estimated $969K.
- 28 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q3 2024, down from 35 in Q2 2024.
- Funds reported $8.08M of Lumos Pharma, Inc. Common Stock stock for Q3 2024, up 68% quarter-over-quarter.
- 2 funds opened new Lumos Pharma, Inc. Common Stock positions in Q3 2024 and 9 closed out, a net change of -7 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q3 2024 was Private Advisor Group, an estimated $1.98M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q3 2024 was Wells Fargo, an estimated $969K sold.
Based on aggregated 13F filings for Q3 2024.